Rhonda Hellums
CFO
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Silence Therapeutics plc (SLN) | Executive Vice President, Chief Financial Officer | $490,000 | $1,150,923 |
| 2024 | Silence Therapeutics plc (SLN) | Executive Vice President, Chief Financial Officer | $466,013 | $1,662,818 |
| 2023 | Silence Therapeutics plc (SLN) | Executive Vice President, Chief Financial Officer | $430,500 | $3,084,844 |
| 2022 | Silence Therapeutics plc (SLN) | Executive Vice President, Chief Financial Officer | $403,958 | $2,383,489 |
Executive changes
Earnings-call appearances
-
Silence Therapeutics plc Q4 FY2024 Earnings Call2025-02-27
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2023 Earnings Call2023-12-31
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2022 Earnings Call2022-12-31
Silence Therapeutics plc (SLN)
-
Silence Therapeutics plc Q4 FY2021 Earnings Call2021-12-31
Silence Therapeutics plc (SLN)